Astra wins EU orphan drug status for cancer drug
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
480028
Indianapolis, November 1 (ots/PRNewswire) - New data presented today confirm that advanced lung cancer patients can look forward to better-quality survival when treated with Alimta(R) (pemetrexed), a newly approved anticancer agent in the European Union
557014
Adding Herceptin to chemotherapy before surgery eradicates tumors in nearly three times as many women with inflammatory breast cancer as chemotherapy alone, the drug's maker Roche Holding AG said on Wednesday.
700311
Biopharmaceutical company Medarex Inc. said Monday that it reached a special protocol assessment agreement with the Food and Drug Administration to start a late-stage clinical trial for its MDX-010 drug as a combination treatment for melanoma patients.
602931
US drug regulators approved Tuesday the targeted anti-cancer treatment Tykerb (lapatinib) for use together with another drug, Xeloda (capectabine) in certain advanced breast cancers.
618283
WEDNESDAY, Oct. 17 (HealthDay News) -- A new chemotherapy drug called Ixempra has received U.S. Food and Drug Administration approval to treat women with advanced breast cancer who haven't responded to three other types of chemotherapy.
410925
An experimental treatment for brain cancer has won approval for commercial use in Switzerland, its London-listed US maker, Northwest Biotherapeutics, Inc., announced on Monday.
758098
German drugmaker Schering AG said on  Thursday that the U.S. Food and Drug Administration had granted  its breast cancer treatment bonefos "priority review" status.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
380448
Biotech company OSI Pharmaceuticals Inc. and biotech giant Genentech Inc. reported Friday that the Food and Drug Administration approved their Tarceva cancer treatment for patients with advanced non-small-cell
309289
Roche Holding, the drug company, has received European Union approval for its colon cancer treatment Avastin.
512456
NEW YORK, September 9 (New Ratings) - The FDA has raised questions regarding AstraZenecaâs (AZN.NYS) blood thinner, Exanta. The leading pharmaceutical companyâs hopes had been pinned on Exanta, which
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
735577
Shares in OSI Pharmaceuticals (OSIP :Nasdaq - news - research) and Genentech (DNA :Nasdaq - news - research) jumped Friday after AstraZeneca (AZN :NYSE - news - research) said new medical data showed its lung cancer drug Iressa provided no survival
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
550215
Biotechnology companies Genentech  Inc. and OSI Pharmaceuticals Inc. on Thursday said U.S.  regulators have approved their drug Tarceva for treating the  most common form of lung cancer.
476212
On Thursday, biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. said US regulators have approved their drug Tarceva for treating the most common form of lung cancer.